dc.contributor.author | Koc, Zehra Pinar | |
dc.contributor.author | Ozcan, Pinar Pelin | |
dc.contributor.author | Ercolak, Vehbi | |
dc.contributor.author | Reyhan, Mehmet | |
dc.date.accessioned | 2022-11-15T08:15:29Z | |
dc.date.available | 2022-11-15T08:15:29Z | |
dc.date.issued | 2022 | |
dc.identifier.issn | 2146-1414 | en_US |
dc.identifier.uri | https://cms.galenos.com.tr/Uploads/Article_50781/MIRT-31-60-En.pdf | |
dc.identifier.uri | http://hdl.handle.net/11727/8100 | |
dc.description.abstract | A 64-year-old male patient with metastatic prostate carcinoma diagnosis received lutetium-177 prostate-specific membrane antigen (PSMA) treatment; however, his disease progressed. Herein, presented the final images of the patient that demonstrated a superscan appearance in the Gallium-68 PSMA positron emission tomography/computed tomography, which is a rare phenomenon. | en_US |
dc.language.iso | eng | en_US |
dc.relation.isversionof | 10.4274/mirt.galenos.2020.78800 | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | PSMA | en_US |
dc.subject | Ga-68 | en_US |
dc.subject | Lu-177 | en_US |
dc.subject | prostate cancer | en_US |
dc.title | Superscan Appearance of Ga-68 PSMA PET/CT in a Patient with Refractory Prostate Cancer | en_US |
dc.type | article | en_US |
dc.relation.journal | MOLECULAR IMAGING AND RADIONUCLIDE THERAPY | en_US |
dc.identifier.volume | 31 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.startpage | 60 | en_US |
dc.identifier.endpage | 62 | en_US |
dc.identifier.wos | 000752525800009 | en_US |
dc.contributor.pubmedID | 35114754 | en_US |
dc.contributor.orcID | https://orcid.org/0000-0001-8550-3368 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | en_US |
dc.contributor.researcherID | AAJ-5242-2021 | en_US |